This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Shionogi Company Limited. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Masato Gomi: Innovator in Pharmaceutical Preparations
Introduction
Masato Gomi is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable and effective drug formulations. His innovative work has led to the creation of a patent that addresses critical challenges in pharmaceutical preparations.
Latest Patents
Masato Gomi holds a patent for a pharmaceutical preparation that excels in light stability and dissolution properties. The invention provides a minimally colored preparation through irradiation with light. This is achieved by coating a preparation containing a specific compound or its pharmaceutically acceptable salt with a light stabilizing substance and a polymer. Notably, titanium oxide and talc are used as light stabilizing substances, while hypromellose serves as the polymer. This innovative approach enhances the quality and effectiveness of pharmaceutical products.
Career Highlights
Gomi is associated with Shionogi Company Limited, a prominent pharmaceutical company known for its commitment to research and development. His work at Shionogi has allowed him to focus on creating advanced pharmaceutical solutions that meet the needs of patients and healthcare providers.
Collaborations
Masato Gomi has collaborated with talented individuals such as Naomi Hayashi and Shohei Aikawa. These partnerships have fostered a creative environment that encourages innovation and the development of groundbreaking pharmaceutical technologies.
Conclusion
Masato Gomi's contributions to the pharmaceutical industry through his innovative patent demonstrate his commitment to improving drug formulations. His work not only enhances the stability and effectiveness of medications but also reflects the importance of collaboration in driving advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
